# FDA 483 - Patrick Clarke, M.D. - May 01, 2021

Source: https://www.globalkeysolutions.net/records/483/patrick-clarke-md/0c1f3d42-0ebd-40a7-b278-bcf4a58560bb

> FDA 483 for Patrick Clarke, M.D. on May 01, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Patrick Clarke, M.D.
- Inspection Date: 2021-05-01
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Patrick Clarke, M.D. in Los Angeles revealed significant deficiencies in the conduct of a clinical study. The firm failed to adhere to the investigational plan and protocol, including not reporting adverse events and numerous protocol deviations. These issues indicate a lack of proper oversight and execution during the clinical trial.

## Related Officers

- [Stuart W. Russell](https://www.globalkeysolutions.net/people/stuart-w-russell/59719ee0-e7b3-4e10-8d87-7c79eb2c2192)

Company: https://www.globalkeysolutions.net/companies/patrick-clarke-md/11421590-5920-4fdc-b0e7-404650e4dd2a

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6